Your browser doesn't support javascript.
loading
Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study.
Werth, Victoria P; Fleischmann, Roy; Robern, Michael; Touma, Zahi; Tiamiyu, Iyabode; Gurtovaya, Oksana; Pechonkina, Alena; Mozaffarian, Afsaneh; Downie, Bryan; Matzkies, Franziska; Wallace, Daniel.
  • Werth VP; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Corporal Michael J. Crescenz VAMC, Philadelphia, PA.
  • Fleischmann R; Department of Internal Medicine, Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Robern M; Dermatology Ottawa Research Center, Ottawa.
  • Touma Z; Division of Rheumatology, Department of Medicine, Toronto Western Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Tiamiyu I; Gilead Sciences, Inc., Foster City.
  • Gurtovaya O; Gilead Sciences, Inc., Foster City.
  • Pechonkina A; Gilead Sciences, Inc., Foster City.
  • Mozaffarian A; Gilead Sciences, Inc., Foster City.
  • Downie B; Gilead Sciences, Inc., Foster City.
  • Matzkies F; Gilead Sciences, Inc., Foster City.
  • Wallace D; Rheumatology, Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Rheumatology (Oxford) ; 61(6): 2413-2423, 2022 05 30.
Article en En | MEDLINE | ID: mdl-34498056
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / Inhibidores de las Cinasas Janus Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / Inhibidores de las Cinasas Janus Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article